Antigen Test Designed for Point-of-Care Detection
By LabMedica International staff writers Posted on 14 Jun 2012 |
A novel antigen-detection test shows efficacy in rapidly identifying a variety of respiratory viruses at the point of care in a pediatric setting.
The automated, MultiAnalyte system, is capable of detecting from a single nasopharyngeal swab specimen eight respiratory viruses including respiratory syncytial virus (RSV); influenza A and B viruses; adenovirus; parainfluenza type 1, 2, and 3 viruses; and Human metapneumovirus.
Scientists at Turku University Hospital (Finland) evaluated the technology's efficacy in a pediatric emergency setting by testing samples from 158 children who had respiratory symptoms or fever, and whose mean age was 1.8 year. The samples were tested by MariPOC as well as by reverse-transcription polymerase chain reaction (RT-PCR).
Results with the MariPOC (ArcDia; Turku, Finland) test showed sensitivities and specificities for viral detection as follows: for the 36 children with RSV, 83% and 99%; for the 20 with influenza B, 85% and 96%; for the six with influenza A, 50% and 99%; for the 12 with adenovirus, 25% and 97%; and for the eight with Metapneumovirus, 50% and 100%.
Lauri Ivaska, MD, the lead author of the study said, "This test is based on fully automated random access immunoassay and delivers preliminary results in 20 minutes and final results in two hours. Approximately 70% of results are ready in 20 minutes. For these purposes we want to make the diagnosis reliable, easy and fast; however, most point-of-care tests for detection of respiratory viruses have limitations in diagnostic performance and clinical usability." Dr. Ivaska added, "The results indicate that whereas sensitivity for influenza and RSV was moderately good, sensitivity for adenovirus was low." The study was presented on May 10, 2012, at the European Society for Pediatric Infectious Diseases (ESPID) 30th Annual Meeting, held in Thessalonica (Greece).
Related Links:
Turku University Hospital
ArcDia
The automated, MultiAnalyte system, is capable of detecting from a single nasopharyngeal swab specimen eight respiratory viruses including respiratory syncytial virus (RSV); influenza A and B viruses; adenovirus; parainfluenza type 1, 2, and 3 viruses; and Human metapneumovirus.
Scientists at Turku University Hospital (Finland) evaluated the technology's efficacy in a pediatric emergency setting by testing samples from 158 children who had respiratory symptoms or fever, and whose mean age was 1.8 year. The samples were tested by MariPOC as well as by reverse-transcription polymerase chain reaction (RT-PCR).
Results with the MariPOC (ArcDia; Turku, Finland) test showed sensitivities and specificities for viral detection as follows: for the 36 children with RSV, 83% and 99%; for the 20 with influenza B, 85% and 96%; for the six with influenza A, 50% and 99%; for the 12 with adenovirus, 25% and 97%; and for the eight with Metapneumovirus, 50% and 100%.
Lauri Ivaska, MD, the lead author of the study said, "This test is based on fully automated random access immunoassay and delivers preliminary results in 20 minutes and final results in two hours. Approximately 70% of results are ready in 20 minutes. For these purposes we want to make the diagnosis reliable, easy and fast; however, most point-of-care tests for detection of respiratory viruses have limitations in diagnostic performance and clinical usability." Dr. Ivaska added, "The results indicate that whereas sensitivity for influenza and RSV was moderately good, sensitivity for adenovirus was low." The study was presented on May 10, 2012, at the European Society for Pediatric Infectious Diseases (ESPID) 30th Annual Meeting, held in Thessalonica (Greece).
Related Links:
Turku University Hospital
ArcDia
Latest Microbiology News
- Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
- Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia
- Rapid AST Platform Provides Targeted Therapeutic Results Days Faster Than Current Standard of Care
- New Analysis Method Detects Pathogens in Blood Faster and More Accurately by Melting DNA